Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC and UC-CM vs Triamcinolone for Keloid Therapy
NCT05887804Phase 4Completed
- Sponsor
- Gatot Soebroto Central Army Hospital
- Start
- Oct 2021
- Primary completion
- Jun 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of human umbilical cord mesenchymal stem cells, human umbilical cord mesenchymal stem cell secretome in keloid, sponsored by Gatot Soebroto Central Army Hospital. Started Oct 2021; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cellshuman umbilical cord mesenchymal stem cell secretome
03
Conditions
keloid
Beyond the preview
Go deeper on NCT05887804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05887804.